- Home
- CVAC vs NMCO Comparison
CVAC vs NMCO Comparison
Compare CVAC & NMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- NMCO
- Stock Information
- Founded
- CVAC 2000
- NMCO 2019
- Country
- CVAC Germany
- NMCO United States
- Employees
- CVAC N/A
- NMCO N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- NMCO Finance/Investors Services
- Sector
- CVAC Health Care
- NMCO Finance
- Exchange
- CVAC Nasdaq
- NMCO Nasdaq
- Market Cap
- CVAC 637.1M
- NMCO 611.6M
- IPO Year
- CVAC 2020
- NMCO N/A
- Fundamental
- Price
- CVAC $2.54
- NMCO $11.12
- Analyst Decision
- CVAC Hold
- NMCO
- Analyst Count
- CVAC 3
- NMCO 0
- Target Price
- CVAC $10.00
- NMCO N/A
- AVG Volume (30 Days)
- CVAC 540.3K
- NMCO 207.6K
- Earning Date
- CVAC 11-12-2024
- NMCO 01-01-0001
- Dividend Yield
- CVAC N/A
- NMCO 5.43%
- EPS Growth
- CVAC N/A
- NMCO N/A
- EPS
- CVAC N/A
- NMCO N/A
- Revenue
- CVAC $70,565,734.00
- NMCO N/A
- Revenue This Year
- CVAC $123.97
- NMCO N/A
- Revenue Next Year
- CVAC N/A
- NMCO N/A
- P/E Ratio
- CVAC N/A
- NMCO N/A
- Revenue Growth
- CVAC 75.11
- NMCO N/A
- 52 Week Low
- CVAC $2.22
- NMCO $8.52
- 52 Week High
- CVAC $6.30
- NMCO $11.64
- Technical
- Relative Strength Index (RSI)
- CVAC 34.97
- NMCO 42.69
- Support Level
- CVAC $2.73
- NMCO $11.04
- Resistance Level
- CVAC $2.97
- NMCO $11.23
- Average True Range (ATR)
- CVAC 0.18
- NMCO 0.15
- MACD
- CVAC -0.01
- NMCO 0.02
- Stochastic Oscillator
- CVAC 7.55
- NMCO 43.18
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About NMCO Nuveen Municipal Credit Opportunities Fund
Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.